Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel

BACKGROUND/AIM: Nab-paclitaxel (Nab-PTX) has been widely used to treat several advanced cancers. Nab-PTX can cause drug-induced lung injury (DILI); however, its clinical and radiographic features have not been clarified. We aimed to assess the clinical characteristics of Nab-PTX-induced lung injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, Keiichiro, Abe, Mitsuhiro, Shiko, Yuki, Koshikawa, Ken, Kawasaki, Yohei, Iwasawa, Shunichiro, Terada, Jiro, Tsushima, Kenji, Tatsumi, Koichiro, Suzuki, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957296/
https://www.ncbi.nlm.nih.gov/pubmed/35345618
http://dx.doi.org/10.2147/DDDT.S342283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957296/
https://www.ncbi.nlm.nih.gov/pubmed/35345618
http://dx.doi.org/10.2147/DDDT.S342283

Ejemplares similares